Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine patch versus placebo for restless legs syndrome in hemodialysis patients
2011-003486-15Phase 3Completed
- Sponsor
- UCB
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in restless legs syndrome (RLS) comparing Rotigotine transdermal patch with Placebo patch (2 arms). Primary endpoint: Reduction of Periodic Limb Movements Index. Started Dec 2011; status: completed.
02
Drugs
rotigotine
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on 2011-003486-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003486-15.